- $36.76bn
- $43.66bn
- $15.44bn
- 76
- 53
- 25
- 50
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 16.32 | ||
| PEG Ratio (f) | 5.52 | ||
| EPS Growth (f) | 3.05% | ||
| Dividend Yield (f) | 4.19% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.28 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 13.62 | ||
| Price to Sales | 2.38 | ||
| EV to EBITDA | 13.97 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 11.17% | ||
| Return on Equity | 11.04% | ||
| Operating Margin | 16.17% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 14,324 | 14,467 | 15,054 | 14,950 | 15,444 | 15,631.25 | 16,177.68 | 1.9% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | +80.38 | -44.77 | +3.03 | -8.21 | +0.07 | +8.76 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Kenvue Inc. is a consumer health company. The Company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include Pain Care; Cough, Cold, and Allergy; and Other Self Care (Digestive Health; Smoking Cessation; Eye Care; and Other). The Skin Health and Beauty segment's product categories include face and body care and hair, sun, and others. The Essential Health segment's product categories include oral care, baby care and other essential health (women’s health, wound care, and other). Its differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec, and Nicorette. The Company has a global footprint through which it sells and distributes its product portfolio in more than 165 countries across its four regions. The four region consists of North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 23rd, 2022
- Public Since
- May 4th, 2023
- No. of Shareholders
- 3,149
- No. of Employees
- 22,000
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
New York Stock Exchange- Shares in Issue
- 1,914,581,851
- Address
- 199 Grandview Road, SKILLMAN, 08558
- Web
- https://www.kenvue.com
- Phone
- +1 7325240400
- Auditors
- PricewaterhouseCoopers LLP
Upcoming Events for KVUE
Q1 2024 Kenvue Inc Earnings Call
Q1 2024 Kenvue Inc Earnings Release
Kenvue Inc Annual Shareholders Meeting
Similar to KVUE
Adtalem Global Education
New York Stock Exchange
Bright Horizons Family Solutions
New York Stock Exchange
Bright Scholar Education Holdings
New York Stock Exchange
Carriage Services
New York Stock Exchange
Church & Dwight Co
New York Stock Exchange
FAQ
What is the Kenvue share price?
As of Today at 19:12 UTC, shares in Kenvue are trading at $19.20. This share price information is delayed by 15 minutes.
How has the Kenvue share price performed this year?
Shares in Kenvue last closed at $19.20 and the price had moved by -28.62% over the past 365 days. In terms of relative price strength the Kenvue share price has underperformed the S&P500 Index by -42.43% over the past year.
What are the analyst and broker recommendations for Kenvue?
The overall consensus recommendation for Kenvue is Hold. You can view the full broker recommendation list by unlocking its StockReport.
What is the Kenvue dividend yield?
The Kenvue dividend yield is 2.08% based on the trailing twelve month period.
Does Kenvue pay a dividend?
Last year, Kenvue paid a total dividend of $0.40, and it currently has a trailing dividend yield of 2.08%.Looking ahead, shares in Kenvue are due to go ex-dividend on 2024-05-07 and the next dividend pay date is 2024-05-22.
When does Kenvue next pay dividends?
Kenvue are due to go ex-dividend on 2024-05-07 and the next dividend pay date is 2024-05-22. The historic dividend yield on Kenvue shares is currently 2.08%.
How do I buy Kenvue shares?
To buy shares in Kenvue you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Kenvue?
As of the previous close price of $19.20, shares in Kenvue had a market capitalisation of $36.76bn.
Where are Kenvue shares listed?
Here are the trading details for Kenvue:
- Country of listing: United States
- Exchange: NYQ
- Ticker Symbol: KVUE
What kind of share is Kenvue?
Based on an overall assessment of its quality, value and momentum Kenvue is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Kenvue share price forecast for 2024?
The analyst consensus target price for shares in Kenvue is $22.09. That is 15.05% above the last closing price of $19.20.
Analysts covering Kenvue currently have a consensus Earnings Per Share (EPS) forecast of $1.14 for the next financial year.
What is the trend in the Kenvue share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Kenvue. Over the past six months, its share price has underperformed the S&P500 Index by -15.6%.
As of the last closing price of $19.20, shares in Kenvue were trading -7.34% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Kenvue PE Ratio?
The Kenvue PE ratio based on its reported earnings over the past 12 months is 16.32. The shares last closed at $19.20.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Kenvue?
We do not have data on Kenvue's directors